Charles R Drew University Master of Science and Clinica*

查尔斯·R·德鲁大学科学与临床硕士*

• 批准号: 6946858
• 负责人: THOMAS Toyokazu YOSHIKAWA
• 金额: $ 53.83万
• 依托单位: CHARLES R. DREW UNIVERSITY OF MED & SCI
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2008-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6946858
• 关键词: clinical research; curriculum; education evaluation /planning; human subject; medical education; science education; university

DESCRIPTION (provided by applicant): In response to the RFA-AR-01-009 entitled "Clinical Research Education and Career Development in Minority Institutions", the Charles R. Drew University of Medicine and Science (Drew) is planning to establish a Master of Science in Clinical Research Degree Program (MSCR) through the College of Medicine. This program represents a dramatic advancement as it will become the first independent degree offered through the College of Medicine. Presently, the Doctor of Medicine degree is jointly conferred through Drew's affiliation with the UCLA School of Medicine. This program represents a new curriculum at Drew that will utilize faculty not only from Drew, but also from the affiliated UCLA institutions, including faculty teaching the recently funded UCLA K-30 Translational Research Curriculum Award. The overarching goal is to train qualified candidates in clinical research methodologies and to impart a unique understanding of the cultural and ethical issues that impact how clinical investigation can contribute to improving the health care of our diverse nation. The core curriculum includes areas such as epidemiology, biostatistics, clinical trials, pharmaco-genetics, research ethics, the communication of science, and grantsmanship. The specific aims of the MSCR Program at Drew are to: 1. Implement a new curriculum for patient-oriented research that has a particular emphasis on methodologies to address health disparities. 2. Increase the number of women and ethnic minority investigators well-trained in health disparities research. 3. Develop a cadre of well-trained clinician faculty who will pursue clinical research on diseases that disproportionately affects minority populations. 4. Continuously evaluate the processes and the initial objectives of the MSCR program and utilize these assessments to make ongoing programmatic improvements in consultation with NIH program officials.

描述(由申请人提供)： 为响应RFA-AR-01-009《少数民族院校的临床研究教育和职业发展》，查尔斯·R·德鲁医学与科学大学(DREW)计划通过医学院设立临床研究理学硕士学位课程(MSCR)。这个项目代表着一个巨大的进步，因为它将成为第一个通过医学院提供的独立学位。目前，医学博士学位是由德鲁与加州大学洛杉矶分校医学院联合授予的。该项目代表了德鲁大学的一项新课程，该课程不仅将使用德鲁大学的教师，还将使用加州大学洛杉矶分校附属机构的教师，包括最近资助的加州大学洛杉矶分校K-30翻译研究课程奖的教师。总体目标是在临床研究方法方面培训合格的候选人，并传授对影响临床研究如何为改善我们多样化国家的医疗保健做出贡献的文化和伦理问题的独特理解。核心课程包括流行病学、生物统计学、临床试验、药物遗传学、研究伦理学、科学传播学和医学研究。德鲁大学MSCR项目的具体目标是： 1.实施新的以病人为中心的研究课程，特别强调解决健康差距的方法。 2.增加受过良好健康差距研究培训的妇女和少数民族调查员人数。 3.培养一支训练有素的临床教员队伍，他们将从事对少数族裔人群影响不成比例的疾病的临床研究。 4.持续评估MSCR计划的流程和初始目标，并与NIH计划官员协商，利用这些评估进行持续的计划改进。